Spain’s Reig Jofre to manufacture J&J’s COVID-19 vaccine in Barcelona By Reuters

© Reuters. FILE PHOTO: Vials and medical syringe are seen in front of J&J logo in this illustration

BARCELONA (Reuters) – Spanish pharmaceutical company Reig Jofre said on Tuesday it had reached an agreement with Johnson & Johnson (NYSE:) to produce the U.S. company’s experimental COVID-19 vaccine at its plant in Barcelona.

J&J’s Janssen subsidiary will transfer the technology required for large-scale manufacture of the vaccine candidate to Reig Jofre, allowing production to get underway once the shot receives regulatory approval, the Spanish company said in a statement.

Under the terms of the agreement, Reig Jofre said it will be responsible for the formulation, filling and packaging of the vaccine, while Janssen will handle distribution.

Shares in the Spanish group surged 17% in early trade to 4.41 euros ($5.35) a share.

Reig Jofre said last month it would able to produce 50 million doses of COVID-19 vaccine a year at its new factory without cancelling any existing contracts.

The company’s new plant in Barcelona is under construction and due to start operating in the first quarter of 2021.

Reig Jofre CEO Ignasi Biosca told Reuters in July the company should have the capacity to produce between one million to two million vaccine doses per day next year.

Biosca said it could invest an additional 2-3 million euros to adapt its new plant for the final step in the production process of putting the COVID-19 vaccine into vials or syringes, such as guaranteeing the low temperature needed to preserve the vaccine.

($1 = 0.8238 euros)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.